Inspire Medical Systems (INSP)
(Delayed Data from NYSE)
$143.74 USD
+5.92 (4.30%)
Updated Jul 19, 2024 04:00 PM ET
After-Market: $143.77 +0.03 (0.02%) 7:58 PM ET
4-Sell of 5 4
D Value B Growth C Momentum D VGM
Fundamental Charts
About PEG Ratio (TTM)
The company's trailing twelve month (TTM) PEG ratio is the P/E ratio divided by its long-term growth rate consensus. This ratio essentially compares the P/E to its growth rate, thus, for many, telling a more complete story than just the P/E ratio alone. Conventional wisdom says that a PEG ratio of 1 or less is considered good (at par or undervalued to its growth rate). A value greater than 1, in general, is not as good (overvalued to its growth rate). For example, a company with a P/E ratio of 25 and a growth rate of 20% would have a PEG ratio of 1.25 (25 / 20 = 1.25). A company with a P/E ratio of 40 and a growth rate of 50% would have a PEG ratio of 0.80 (40 / 50 = 0.80). Traditionally, investors would look at the stock with the lower P/E and deem it a bargain. But when compared to its growth rate, it doesn't have the earnings growth to justify its P/E. In this example, the one with the P/E of 40 is the better bargain because it is selling at a discount to its growth rate. So the PEG ratio tells you what you're paying for each unit of earnings growth.
INSP 143.74 +5.92(4.30%)
Will INSP be a Portfolio Killer in July?
Zacks Investment Research is releasing its prediction for INSP based on the 1-3 month trading system that more than doubles the S&P 500.
Zacks News for INSP
Inspire Medical (INSP) Dips on FDA Recall of IPG Model 3028
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
INSP: What are Zacks experts saying now?
Zacks Private Portfolio Services
Why This 1 Momentum Stock Could Be a Great Addition to Your Portfolio
Why Is Inspire (INSP) Down 7.3% Since Last Earnings Report?
Three Reasons to Retain Inspire Medical (INSP) Stock for Now
Other News for INSP
Inspire Medical Systems, Inc. Announces CE Mark Certification under the European Union’s Medical Device Regulation for Inspire Therapy
Inspire announces CE mark certification under EU MDR for Inspire Therapy
Inspire announces EU MDR approved additional MRI conditions for Inspire Therapy
Med-tech and healthcare stocks with upside during 2Q earnings - Baird
Inspire Medical price target lowered by $63 at Truist, here's why